Tenosynovitis of Hand Flexor Tendons
Conditions
Interventions
Group Dynamic Essential Oil:Apply the dynamic essential oil to the affected area and the surrounding skin 2-3 times a day, gently massage until fully absorbed. About 10 drops are needed for an area th
Group Voltaren:Rub the painful area of fingers with about 3 cm each time, once a day according to the instructions. Continue for 2 weeks.
Sponsors
Sun Yat-sen Memorial Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The clinical diagnostic criteria for flexor tenosynovitis are met, including localized thickening and swelling of the tendon sheath, pain during finger flexion and extension exacerbated upon waking or after exertion, as well as restricted finger mobility potentially accompanied by triggering or snapping phenomena; 2.Symptoms persist for at least 4 weeks, while no glucocorticoid treatment or surgical intervention has been received; 3. The score of VAS Scale >= 5; 4. The scale of Quinnell grading <= 3; 5 Sign the informed consent form, commit to fully participating in the research, and abide by the treatment plan, for example, avoiding the simultaneous use of other treatment methods; 6.No history of fragrance oil allergy, no severe skin diseases such as eczema and open wounds, no systemic or local skin infections.
Exclusion criteria
Exclusion criteria: 1. Carrying other hand-related diseases, such as carpal tunnel syndrome, rheumatoid arthritis, gouty arthritis, etc; 2. Received local glucocorticoid injection or physical therapy within the past 4 weeks, have been using non-steroidal anti-inflammatory drugs (NSAIDs) or immunosuppressants for a long time (the medication needs to be discontinued for at least 2 weeks before enrollment); 3. Those with severe systemic diseases (such as diabetes, uncontrolled cardiovascular diseases, liver or kidney dysfunction), as well as pregnant or lactating women; 4. The previous conservative treatment was administered for more than 3 months while the effect was not satisfactory; 5. Those with poor compliance, such as those with cognitive impairments or mental disorders; 6. Those who have participated in other clinical trials recently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Scale Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Grip Strength;QuickDASH Scale Score;Pinch Strength; | — |
Countries
China
Contacts
Public ContactHou Jingyi
Sun Yat-sen Memorial Hospital
Outcome results
None listed